CM

CMS Medical Venture Investment

Europe, Cambridgeshire, United Kingdom, Cambridge

Description

CMS Medical Venture Investment

Investor Profile

CMS Medical Venture Investment has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in France, United Kingdom.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Biopharma.

Stage Focus

  • Series B (67%)
  • Post Ipo Equity (33%)

Country Focus

  • France (67%)
  • United Kingdom (33%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Biopharma
  • Therapeutics
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CMS Medical Venture Investment frequently co-invest with?

Mirae Asset Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
GO CAPITAL
Europe, Bretagne, France, Rennes
Co-Investments: 1
Co-Investments: 1
Newton Biocapital
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Anaxago
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Downing LLP
Europe, England, United Kingdom, London
Co-Investments: 1
Mirae Asset
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Karista
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by CMS Medical Venture Investment?

Acticor Biotech

Paris, Ile-de-France, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series BNov 6, 2019
Amount Raised: $7,749,106
Acticor Biotech

Paris, Ile-de-France, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series BOct 17, 2018
Amount Raised: $17,596,907
Destiny Pharma

Brighton, East Sussex, United Kingdom

Destiny Pharma Ltd., a clinical stage pharmaceutical company

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityDec 4, 2017
Amount Raised: $24,656,427

Find More Investors Like CMS Medical Venture Investment

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

CMS Medical Venture Investment | Pipeseed